Novavax Approved as Booster Alternative for Australians 18 and Over

Vials labeled "COVID-19 Coronavirus Vaccine" and syringe are seen in front of displayed Novavax logo in this illustration taken on Feb. 9, 2021. Dado Ruvic/Illustration/Reuters

The Novavax COVID-19 protein vaccine has been approved by the ATAGI as a booster alternative to mRNA vaccines for Australians aged 18 and over.

The ATAGI stated (pdf) that the Novavax COVID-19 vaccine currently has “limited evidence” on its safety and immunogenicity as a booster, but is acceptable as a third shot if “no other COVID-19 vaccine is suitable for that individual.”